Analyst Research

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Sadif Analytics Prime
$25.00
Provider: Sadif Analytics Prime
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Eckert & Ziegler Bebig SA to Acquire BTG plc's Biocompatibles Inc.


Tuesday, 17 Sep 2013 01:51am EDT 

Eckert & Ziegler Bebig SA announced that it has concluded an agreement to acquire the brachytherapy business of Biocompatibles Inc., a subsidiary of BTG plc. This company is based in Oxford, Connecticut (USA). Completion of the acquisition is subject to customary closing conditions and is scheduled to take effect within the next 30 days. The purchase price is approximately USD 5 million plus a 30% share in sales revenues during the first year. Biocompatibles Inc. specializes primarily in the processing and optimization of prostate implants in the United States. In 2012, Biocompatibles Inc., which has 48 employees, generated worldwide sales of approximately EUR 8 million with the divested business segment. 

Latest Developments for Eckert & Ziegler BEBIG SA